ENDRA Life Sciences Inc.

NDRANasdaqCIK 1681682HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 194 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

ENDRA Life Sciences Inc., Reports and events
Filed	Form	What it is	Accession number
2021-11-1516:18 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001654954-21-012220
2021-08-1217:01 ET	10-Q	Quarterly reportPeriod 2021-06-30	0001654954-21-008864
2021-08-1216:06 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001654954-21-008841
2021-06-2116:58 ET	8-K	1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits	0001654954-21-007094
2021-06-1509:01 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001654954-21-006899
2021-06-0817:25 ET	8-K	5.07 Shareholder vote results	0001654954-21-006684
2021-05-1717:02 ET	10-Q	Quarterly reportPeriod 2021-03-31	0001654954-21-005911
2021-05-1716:05 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001654954-21-005871
2021-04-2916:09 ET	DEF 14A	Proxy statementPeriod 2021-06-08	0001654954-21-004804
2021-04-2707:01 ET	8-K	2.02 Results of operations; 8.01 Other events	0001654954-21-004654
2021-03-2517:06 ET	10-K	Annual reportPeriod 2020-12-31	0001654954-21-003302
2021-03-2516:05 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001654954-21-003292
2021-03-0508:10 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001654954-21-002404
2021-02-1916:13 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001654954-21-001916
2021-02-0307:14 ET	8-K	8.01 Other events	0001654954-21-001109
2021-01-1117:05 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001654954-21-000306
2020-12-3016:46 ET	8-K	8.01 Other events	0001654954-20-014026
2020-12-2117:18 ET	8-K	1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001654954-20-013801
2020-12-1817:04 ET	8-K	1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits	0001654954-20-013753
2020-12-1516:04 ET	8-K	1.02 Termination of a material agreement	0001654954-20-013567
2020-12-1417:23 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001654954-20-013538
2020-11-1617:01 ET	10-Q	Quarterly reportPeriod 2020-09-30	0001654954-20-012515
2020-11-1616:05 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001654954-20-012472
2020-09-2516:54 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001654954-20-010481
2020-09-2417:09 ET	8-K	1.02 Termination of a material agreement	0001654954-20-010426
2020-09-0216:05 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001654954-20-009764
2020-08-2116:36 ET	8-K	3.01 Delisting notice; 5.07 Shareholder vote results	0001654954-20-009423
2020-08-1716:02 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001654954-20-009242
2020-08-1416:02 ET	10-Q	Quarterly reportPeriod 2020-06-30	0001654954-20-009164
2020-08-0316:10 ET	DEF 14A	Proxy statementPeriod 2020-08-13	0001654954-20-008321
2020-07-2217:23 ET	8-K	8.01 Other events	0001654954-20-007924
2020-06-1817:01 ET	8-K	5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001654954-20-006789
2020-06-0108:02 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001654954-20-006146
2020-05-1417:24 ET	10-Q	Quarterly reportPeriod 2020-03-31	0001654954-20-005509
2020-05-1416:04 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001654954-20-005473
2020-04-2916:16 ET	DEF 14A	Proxy statementPeriod 2020-06-16	0001654954-20-004632
2020-04-2716:01 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.01 Delisting notice	0001654954-20-004473
2020-04-1316:29 ET	8-K	5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001654954-20-003997
2020-04-0316:54 ET	8-K	8.01 Other events	0001654954-20-003787
2020-03-2717:19 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001654954-20-003393
2020-03-2617:21 ET	10-K	Annual reportPeriod 2019-12-31	0001654954-20-003346
2020-03-2616:07 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001654954-20-003330
2020-03-1008:02 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001654954-20-002407
2020-01-1510:12 ET	8-K	1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001654954-20-000453
2019-12-2716:06 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001654954-19-014269
2019-12-2616:15 ET	8-K	1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001654954-19-014235
2019-12-1909:17 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001654954-19-014072
2019-12-1317:21 ET	8-K/A	1.01 Entry into a material agreement	0001654954-19-013920
2019-12-1117:14 ET	8-K	1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001654954-19-013822
2019-11-1317:02 ET	10-Q	Quarterly reportPeriod 2019-09-30	0001654954-19-012855

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 17:03 ET. Listed shows no prices and gives no investment advice.